If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Ester Simeone is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Melanoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Survival Medicine & Life Sciences
temozolomide Medicine & Life Sciences
fotemustine Medicine & Life Sciences
Neutrophils Medicine & Life Sciences
Lymphocytes Medicine & Life Sciences
Electrochemotherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2020

Nivolumab for the treatment of small cell lung cancer

Simeone, E., Grimaldi, A. M., Festino, L., Trojaniello, C., Vitale, M. G., Vanella, V., Curvietto, M. & Ascierto, P. A., 2020, In : Expert Review of Respiratory Medicine.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Drug Therapy
Clinical Trials
6 Citations (Scopus)

Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations

Ascierto, P. A., Capone, M., Grimaldi, A. M., Mallardo, D., Simeone, E., Madonna, G., Roder, H., Meyer, K., Asmellash, S., Oliveira, C., Roder, J. & Grigorieva, J., Mar 29 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 91.

Research output: Contribution to journalArticle

Disease-Free Survival

Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab

(IMI), O. B. O. T. I. M. I., Pistillo, M. P., Fontana, V., Morabito, A., Dozin, B., Laurent, S., Carosio, R., Banelli, B., Ferrero, F., Spano, L., Tanda, E., Ferrucci, P. F., Martinoli, C., Cocorocchio, E., Guida, M., Tommasi, S., De Galitiis, F., Pagani, E., Antonini Cappellini, G. C., Marchetti, P. & 9 others, Quaglino, P., Fava, P., Osella-Abate, S., Ascierto, P. A., Capone, M., Simeone, E., Romani, M., Spagnolo, F. & Queirolo, P., 2019, In : Cancer Immunology and Immunotherapy.

Research output: Contribution to journalArticle

Survival Analysis

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

Capone, M., Mallardo, D., Madonna, G., Festino, L., Grimaldi, A. M., Vanella, V., Simeone, E., Paone, M., Palmieri, G., Cavalcanti, E., Caracò, C. & Ascierto, P. A., Jul 16 2018, In : Journal for ImmunoTherapy of Cancer. 6, 1, p. 74

Research output: Contribution to journalArticle

Disease-Free Survival
1 Citation (Scopus)
Conflict of Interest